• Home
  • The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study.

The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study.

Author List
Alexander J. Ehrenberg, Kun Leng, Kaitlin Letourneau, Israel Hernandez, Caroline Lew, William W. Seeley, Salvatore Spina, Bruce L. Miller, Helmut Heinsen, Martin Kampmann, Kenneth S. Kosik, Lea T. Grinberg
Publication
Alzheimer's & Dementia
Publication ID (Profile URL)
https://researcherprofiles.org/profile/253792916
Publication Year
2021
Publication Title
Alexander J. Ehrenberg, Kun Leng, Kaitlin Letourneau, Israel Hernandez, Caroline Lew, William W. Seeley, Salvatore Spina, Bruce L. Miller, Helmut Heinsen, Martin Kampmann, Kenneth S. Kosik, Lea T. Grinberg. The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study. Alzheimer's & Dementia. 2021 Dec 31; 17(S5).